This ad will auto close in 10 seconds

Cipla grants global rights to Meda for nasal spray 'Dymista'

Cipla Wednesday said it has granted the global commercialisation rights for its nasal spray 'Dymista' to Swedish partner Meda AB except for certain geographies.

Sun Pharma shares fall over talks to buy Sweden's Meda

Sun Pharmaceutical’s share prices fell as much as 2.23 percent on Monday amidst reports that it is in talks to buy Sweden's Meda AB for over $5 billion.

Sun in talks to buy Sweden's Meda for up to $5 bn: Reports

Drug major Sun Pharmaceutical Industries is said to be in talks to buy Sweden's pharma firm Meda AB in a deal worth up to USD 5 billion, according to media reports.

Sun Pharmaceutical in talks to buy Meda for over $5 bn: Report

The pharma company’s stocks last traded down 2.54% at Rs 1,045.50 for the week ended yesterday.